BIOCON.NS Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 11:59):

Stats
Dagens volum	17.30M
Gjennomsnittsvolum	8.13M
Markedsverdi	367.56B
EPS	INR0 ( 2024-02-08 )
Neste inntjeningsdato	( INR1.300 ) 2024-05-16
Last Dividend	INR1.500 ( 2023-07-06 )
Next Dividend	INR0 ( N/A )
P/E	30.55
ATR14	INR0.416 (0.14%)

Volum Korrelasjon

Lang: -0.21 (neutral)

Kort: 0.75 (moderate)

Signal:(47.021) Neutral

Biocon Limited Korrelasjon

10 Mest positive korrelasjoner
APLLTD.NS	0.953
MSUMI.NS	0.946
IMPEXFERRO.NS	0.943
NAVNETEDUL.NS	0.942
LICNFNHGP.NS	0.938
TATACONSUM.NS	0.935
TATACOFFEE.NS	0.933
ICICI500.NS	0.93
ENIL.NS	0.929
ICICINF100.NS	0.929

10 Mest negative korrelasjoner
4THDIM.NS	-0.948
JSL.NS	-0.925
LTGILTBEES.NS	-0.908
RAJRILTD.NS	-0.906
ISMTLTD.NS	-0.9
KIRLFER.NS	-0.876
JSLHISAR.NS	-0.869
SUNFLAG.NS	-0.864
OIL.NS	-0.86
DFMFOODS.NS	-0.859

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Biocon Limited Korrelasjon - Valuta/Råvare

0.19
( neutral )

0.25
( neutral )

0.63
( weak )

0.11
( neutral )

-0.61
( weak negative )

0.53
( weak )

Biocon Limited Økonomi

Annual	2022
Omsetning:	INR111.74B
Bruttogevinst:	INR75.11B (67.22 %)
EPS:	INR3.88

FY	2022
Omsetning:	INR111.74B
Bruttogevinst:	INR75.11B (67.22 %)
EPS:	INR3.88

FY	2022
Omsetning:	INR80.25B
Bruttogevinst:	INR53.01B (66.06 %)
EPS:	INR5.44

FY	2021
Omsetning:	INR69.70B
Bruttogevinst:	INR47.60B (68.29 %)
EPS:	INR6.24

Financial Reports:

No articles found.

Biocon Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR1.500 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Biocon Limited Dividend Information - Dividend Junior

Dividend Sustainability Score: 6.47 - average (82.41%) | Divividend Growth Potential Score: 2.72 - Decrease likely (45.69%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR0.0833	2004-07-01
Last Dividend	INR1.500	2023-07-06
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	19	--
Total Paid Out	INR10.21	--
Avg. Dividend % Per Year	0.18%	--
Score	1.84	--
Div. Sustainability Score	6.47
Div.Growth Potential Score	2.72
Div. Directional Score	4.59	--

Next Divdend (Est)
(2024-06-14)

INR1.691 Estimate 3.08 %

Dividend Stability

0.25 Very Poor

Dividend Score

1.84

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield
2004	INR0	0.00%
2005	INR0	0.00%
2006	INR0	0.00%
2007	INR0	0.00%
2008	INR0	0.00%
2009	INR0	0.00%
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR0.500	0.16%
2019	INR0.500	0.16%
2020	INR0	0.00%
2021	INR0	0.00%
2022	INR0.500	0.14%
2023	INR1.500	0.57%
2024	INR0	0.00%

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SIYSIL.NS	Dividend Junior	2023-07-24	Semi-Annually	18	1.37%
MEDICAMEQ.NS	Ex Dividend Junior	2023-09-20	Annually	3	0.02%
GULFOILLUB.NS	Dividend Junior	2023-08-25	Annually	11	2.19%
BBTC.NS	Dividend Junior	2023-09-22	Annually	22	0.08%
PRESTIGE.NS	Dividend Junior	2023-09-14	Annually	14	0.25%
KANSAINER.NS	Dividend Junior	2023-05-25	Annually	21	0.49%
EIHAHOTELS.NS	Dividend Junior	2023-07-31	Sporadic	17	0.31%
ADVENZYMES.NS	Dividend Junior	2023-08-04	Annually	8	0.59%
SUBROS.NS	Dividend Junior	2023-08-22	Annually	20	0.22%
NAHARSPING.NS	Dividend Junior	2023-09-08	Annually	18	0.74%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0845	1.500	8.31	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0216	1.200	9.28	10.00	[0 - 0.3]
returnOnEquityTTM	0.0636	1.500	-0.404	-0.606	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.104	0.800	9.48	7.59	[1 - 3]
quickRatioTTM	0.627	0.800	-1.018	-0.814	[0.8 - 2.5]
cashRatioTTM	0.135	1.500	-0.359	-0.539	[0.2 - 2]
debtRatioTTM	0.291	-1.500	5.16	-7.74	[0 - 0.6]
interestCoverageTTM	2.65	1.000	-0.128	-0.128	[3 - 30]
operatingCashFlowPerShareTTM	20.50	2.00	3.17	6.33	[0 - 30]
freeCashFlowPerShareTTM	20.50	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.817	-1.500	6.73	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.662	1.000	2.29	2.29	[0.2 - 0.8]
operatingProfitMarginTTM	0.186	1.000	8.28	8.28	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.153	1.000	-0.264	-0.264	[0.2 - 2]
assetTurnoverTTM	0.256	0.800	-1.628	-1.302	[0.5 - 2]
Total Score				6.47

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	31.01	1.000	6.97	0	[1 - 100]
returnOnEquityTTM	0.0636	2.50	-0.260	-0.606	[0.1 - 1.5]
freeCashFlowPerShareTTM	20.50	2.00	3.17	10.00	[0 - 30]
dividendYielPercentageTTM	0.484	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	20.50	2.00	3.17	6.33	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-24.49	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.173	1.000	8.17	0	[0.1 - 0.5]
Total Score				2.72

Biocon Limited

Biocon Limited, a biopharmaceutical company, manufactures pharmaceuticals, and medicinal chemical and botanical products. The company operates through Generics, Novel Biologics, Biosimilars, and Research Services segments. It focuses in the areas of diabetes, oncology, immunology, ophthalmology, and bone health diseases. In addition, It is involved in the integrated discovery, development, and manufacturing services for small and large molecules. The company serves customers in approximately 120 countries. Biocon Limited was founded in 1978 and is headquartered in Bengaluru, India.